Rennova Health Statistics
Total Valuation
Rennova Health has a market cap or net worth of $4.31 million. The enterprise value is $16.42 million.
Market Cap | 4.31M |
Enterprise Value | 16.42M |
Important Dates
The last earnings date was Thursday, December 12, 2019, before market open.
Earnings Date | Dec 12, 2019 |
Ex-Dividend Date | n/a |
Share Statistics
Rennova Health has 43.05 billion shares outstanding. The number of shares has increased by 197.09% in one year.
Shares Outstanding | 43.05B |
Shares Change (YoY) | +197.09% |
Shares Change (QoQ) | -93.49% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 6.69% |
Float | n/a |
Valuation Ratios
The trailing PE ratio is 0.00.
PE Ratio | 0.00 |
Forward PE | n/a |
PS Ratio | 0.21 |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | 1.16 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.31, with an EV/FCF ratio of 4.41.
EV / Earnings | 6.94 |
EV / Sales | 0.81 |
EV / EBITDA | 3.31 |
EV / EBIT | 3.57 |
EV / FCF | 4.41 |
Financial Position
Current Ratio | n/a |
Quick Ratio | 0.11 |
Debt / Equity | n/a |
Debt / EBITDA | 2.47 |
Debt / FCF | 3.28 |
Interest Coverage | 13.50 |
Financial Efficiency
Return on equity (ROE) is -8.59% and return on invested capital (ROIC) is -19.12%.
Return on Equity (ROE) | -8.59% |
Return on Assets (ROA) | 11.92% |
Return on Capital (ROIC) | -19.12% |
Revenue Per Employee | $238,855 |
Profits Per Employee | $27,840 |
Employee Count | 85 |
Asset Turnover | n/a |
Inventory Turnover | 27.77 |
Taxes
In the past 12 months, Rennova Health has paid $591,810 in taxes.
Income Tax | 591,810 |
Effective Tax Rate | 20.01% |
Stock Price Statistics
Beta (1Y) | 53.11 |
52-Week Price Change | n/a |
50-Day Moving Average | 0.00 |
200-Day Moving Average | 0.00 |
Relative Strength Index (RSI) | 53.71 |
Average Volume (30 Days) | 38,485,226 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.84 |
Income Statement
In the last 12 months, Rennova Health had revenue of $20.30 million and earned $2.37 million in profits. Earnings per share was $0.05.
Revenue | 20.30M |
Gross Profit | 12.81M |
Operating Income | 3.65M |
Pretax Income | 3.01M |
Net Income | 2.37M |
EBITDA | 4.96M |
EBIT | 4.60M |
Earnings Per Share (EPS) | $0.05 |
Balance Sheet
The company has $123,898 in cash and $12.24 million in debt, giving a net cash position of -$12.11 million or -$0.00 per share.
Cash & Cash Equivalents | 123,898 |
Total Debt | 12.24M |
Net Cash | -12.11M |
Net Cash Per Share | -$0.00 |
Equity / Book Value | -27.56M |
Book Value Per Share | -0.00 |
Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was $4.05 million and capital expenditures -$323,963, giving a free cash flow of $3.73 million.
Operating Cash Flow | 4.05M |
Capital Expenditures | -323,963 |
Free Cash Flow | 3.73M |
FCF Per Share | $0.00 |
Margins
Gross margin is 63.10%, with operating and profit margins of 17.96% and 11.66%.
Gross Margin | 63.10% |
Operating Margin | 17.96% |
Pretax Margin | 14.83% |
Profit Margin | 11.66% |
EBITDA Margin | 24.45% |
EBIT Margin | 22.63% |
FCF Margin | 18.36% |
Dividends & Yields
Rennova Health does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -197.09% |
Shareholder Yield | -197.09% |
Earnings Yield | 54.97% |
FCF Yield | 86.56% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 16, 2022. It was a reverse split with a ratio of 1:10000.
Last Split Date | Mar 16, 2022 |
Split Type | Reverse |
Split Ratio | 1:10000 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 6 |